<DOC>
	<DOCNO>NCT00162253</DOCNO>
	<brief_summary>The purpose clinical research study learn BMS-587101 effective treatment Moderate Severe Psoriasis . The safety treatment also study .</brief_summary>
	<brief_title>Study BMS-587101 Patients With Moderate Severe Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Otherwise healthy individual diagnosis plaquetype psoriasis least 6 month prior screen ( subject concurrent psoriatic arthritis may enrol ) . Men Women Not Child Bearing Potential ( i.e . woman postmenopausal surgically sterile ) , woman age 18 75 . Women Child Bearing Potential unwilling unable use acceptable method avoid pregnancy entire study period 4 week study . Known suspect infection , include infection human immunodeficiency virus ( HIV ) , hepatitis B C virus . Any recent infection require antibiotic treatment complete within 4 week enrollment . Any known malignancy history malignancy within 5 year prior enrollment , exception basal cell squamous cell carcinoma skin excise evidence recurrence ( squamous cell carcinoma location exclusionary ) . Any history GuillaneBarre syndrome . History keloid formation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2007</verification_date>
</DOC>